论文部分内容阅读
采用酶联免疫吸附试验（ＥＬＩＳＡ）测定５６例动脉粥样硬化性脑梗塞和３３例腔隙性脑梗塞患者血浆氧化修饰低密度脂蛋白（ＯＸＬＤＬ）浓度，旨在研究ＯＸＬＤＬ测定在缺血性脑卒中（ＩＣＶＤ）诊断中的应用。结果显示ＩＣＶＤ各组血浆ＯＸＬＤＬ浓度均不同程度地高于对照组，差别均具有显著意义（Ｐ＜０．０１）。动脉粥样硬化性脑梗塞组高于腔隙性脑梗塞组（Ｐ＜０．０１）。提示血浆ＯＸＬＤＬ浓度升高与发生动脉粥样硬化性脑梗塞有关，血浆ＯＸＬＤＬ浓度可作为动脉粥样硬化性脑梗塞常规性的辅助诊断指标。
Enzyme-linked immunosorbent assay (ELISA) was used to determine the concentration of oxidized low density lipoprotein (OXLDL) in 56 patients with atherosclerotic cerebral infarction and 33 patients with lacunar infarction. The aim of this study was to investigate the effect of OXLDL in ischemic brain Stroke (ICVD) diagnosis. The results showed that the plasma concentrations of OXLDL in ICVD groups were all higher than those in the control group, the difference was significant (P <0.01). Atherosclerotic cerebral infarction group than lacunar infarction group (P <0.01). Prompted plasma OXLDL concentration and occurrence of atherosclerotic cerebral infarction, plasma OXLDL concentration can be used as routine auxiliary diagnosis of atherosclerotic cerebral infarction.